Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PGEN · against 429 other Healthcare companies of similar size
Ranked #388 of 430 · scores higher than 10% of peers · safety percentile 11
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)42 peers with a safety percentile of 10–19, including PGEN · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | PGEN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 407 reported | 2.26× | 0.23× | 5% | 33% | |
| BetaLower is better · 405 reported | 1.02 | 0.53 | 23% | 33% | |
| Current ratioHigher is better · 415 reported | 4.58× | 2.79× | 68% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 1.1B USD | 100 | ||
| 5 | 3.6B USD | 99 | ||
| 384 | 2.2B CAD (≈$1.6B) | 12 | 44 | |
| 385 | 1.1B USD | 12 | 32 | |
| 386 | 1.9B USD | 11 | 38 | |
| 387 | 1.6B USD | 11 | 52 | |
| 388 | 1.9B USD | 11 | 32 | |
| 389 | 1.0B EUR (≈$1.1B) | 11 | 16 | |
| 390 | 2.7B CAD (≈$2.0B) | 10 | 54 | |
| 391 | 1.6B USD | 10 | 43 | |
| 392 | 1.6B USD | 10 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score